EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

PD-L1 Aptamer–Functionalized Mesoporous Silica Nanoparticles for Targeted Doxorubicin Delivery in Triple-Negative Breast Cancer

Juntao Tan, Zixi Hu, Da Huang, Lu Chen, Liangliang Min, Qi-Hua Jiang, Zhihua Li

International Journal of Nanomedicine · 2026-10 · Volume 21 · 1-15

DOI: 10.2147/ijn.s640426 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2026-10. Verfasst von Juntao Tan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Jiangxi Province Key Laboratory of Breast Diseases, Nanchang People's Hospital/The Affiliated Nanchang People's Hospital of Nanchang Medical College,…. Hauptthemen laut MEDLINE: Doxorubicin, Silicon Dioxide, Triple Negative Breast Neoplasms, Aptamers, Nucleotide. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinSilicon DioxideTriple Negative Breast NeoplasmsAptamers, NucleotideB7-H1 AntigenNanoparticlesHumansAnimalsFemaleMiceMDA-MB-231 CellsCell Line, TumorMice, NudePorosityCell SurvivalXenograft Model Antitumor AssaysMice, Inbred BALB CDrug CarriersAntibiotics, Antineoplastic

Stichwörter der Autor:innen

PD-L1 aptamerdoxorubicinmesoporous silica nanoparticlestargeted drug deliverytriple-negative breast cancer

Substanzen

DoxorubicinSilicon DioxideAptamers, NucleotideB7-H1 AntigenCD274 protein, humanDrug CarriersAntibiotics, Antineoplastic

Autor:innen und Institutionen

  • Jiangxi Province Key Laboratory of Breast Diseases, Nanchang People's Hospital/The Affiliated Nanchang People's Hospital of Nanchang Medical College, Nanchang, Jiangxi, People's Republic of China.
  • Clinical Laboratory Center, The First Affiliated Hospital of Guilin Medical University, Guilin, Guangxi Zhuang Autonomous Region, People's Republic of China.
  • Department of Breast Surgery, Nanchang People's Hospital/The Affiliated Nanchang People's Hospital of Nanchang Medical College, Nanchang, Jiangxi, People's Republic of China.

Zitieren

APA

Tan, J., Hu, Z., Huang, D., Chen, L., Min, L., Jiang, Q. H., & Li, Z. (2026). PD-L1 Aptamer–Functionalized Mesoporous Silica Nanoparticles for Targeted Doxorubicin Delivery in Triple-Negative Breast Cancer. International Journal of Nanomedicine, Volume 21, 1-15. https://doi.org/10.2147/ijn.s640426

Vancouver

Tan J, Hu Z, Huang D, Chen L, Min L, Jiang QH, et al. PD-L1 Aptamer–Functionalized Mesoporous Silica Nanoparticles for Targeted Doxorubicin Delivery in Triple-Negative Breast Cancer. International Journal of Nanomedicine. 2026;Volume 21:1-15. doi:10.2147/ijn.s640426

BibTeX
@article{Tan2026,
  author = {Tan, Juntao and Hu, Zixi and Huang, Da and Chen, Lu and Min, Liangliang and Jiang, Qi-Hua and Li, Zhihua},
  title = {PD-L1 Aptamer–Functionalized Mesoporous Silica Nanoparticles for Targeted Doxorubicin Delivery in Triple-Negative Breast Cancer},
  journal = {International Journal of Nanomedicine},
  year = {2026},
  volume = {Volume 21},
  pages = {1--15},
  doi = {10.2147/ijn.s640426}
}
Kostenlos starten →